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OBJECTIVE: Health-related utility is poorly characterised in
stroke patients with limb spasticity. The purpose of this study
was to evaluate health utility in stroke patients with and without
upper and lower limb spasticity. METHODS: Data were
abstracted from the Health Outcomes Data Repository
(HODaR) describing treatment patterns, outcomes and quality
of life following a modiﬁed survey describing 151 patients 
who had experienced a stroke in the last two years. Data were
available describing demographics, the EQ5D and the pres-
ence/absence of self reported limb spasticity. These data were
then linked to routine hospital inpatient data. RESULTS: The
mean age was 72.4 years (56% males). One quarter (26.5%) of
respondents reported no limb spasticity. Of the remainder,
13.9% reported upper limb spasticity only, 11.2% lower limb
spasticity only, and 27.2% a combination of both. Overall, the
mean EQ5Dindex for these patients was 0.55, although patients
reporting no limb spasticity had a higher EQ5Dindex (0.73) com-
pared to those reporting lower limb spasticity (0.36; D = 0.37).
There was a notable difference in utility between those with
upper and lower limb spasticity where patients reporting lower
limb spasticity had lower health utility (0.36 vs. 0.62 respec-
tively; D = 0.26). A similar pattern existed in their duration of
hospital stay with patients experiencing upper and lower limb
spasticity having a mean length of stay of 42.7 days compared
to 29.1 days (lower limb spasticity only) and 20.5 days (upper
limb spasticity only). Patients reporting no limb spasticity had a
mean length of stay of 10.2 days. CONCLUSIONS: The mean
utility estimates obtained from this study show stroke patients
experienced a substantial decrease in quality of life and a further
decrease was recorded in those patients reporting upper and/or
lower limb spasticity. Limb spasticity was also associated with a
substantial increase in hospital length of stay.
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OBJECTIVES: Anticoagulation with warfarin for stroke pre-
vention requires careful management to avoid hemorrhage or
thrombosis. We evaluated the frequency of international nor-
malized ratio (INR) testing in two high-risk Medicare popula-
tions who are likely to receive adjusted-dose warfarin: 1) patients
diagnosed with atrial ﬁbrillation (AF); and 2) patients with a
mechanical heart valve (MHV). METHODS: We analyzed the
2001 Physician Supplier Procedure Summary Master Files
(PSPSMF) database, a 5% sample of procedure-speciﬁc claims
for all physician/supplier services rendered to Medicare beneﬁ-
ciaries. We identiﬁed patients with AF and MHV based on 
any-listed ICD-9-CM diagnosis code of 427.31 and V43.3,
respectively. For each cohort, we searched for claims billed 
under Current Procedural Terminology (CPT) code 85610—
prothrombin testing. We compared prevalence and frequency of
INR testing for each cohort to expected standards of care.
RESULTS: We identiﬁed 141,757 patients with AF and 10,055
patients with MHV, which would yield projected national esti-
mates of 2.8 million and 200,000 patients, respectively. Sixty
percent of AF patients and 43% of MHV patients did not have
a single INR claim. Of AF patients who had at least one INR
test claim, 41% were tested less than 6 times per year, and 59%
were tested 10 or fewer times per year. For MHV patients, 31%
were tested less than 6 times per year, and 47% were tested 10
or fewer times per year. CONCLUSIONS: Medicare claims his-
tories reveal that clinical practice patterns may not adhere to
accepted standards of care for the prevention of stroke in AF and
MHV. Third-party payment policies, provider behavior, lack of
patient awareness, and other factors may contribute to poor
compliance and possible adverse events. Additional studies are
needed to determine the cause of under-compliance in managing
patients at risk for stroke and how Medicare policies may affect
prescribing decisions and patient outcomes.
PSR5
CONTINUITY OF CARE IN STROKE PATIENTS UNDER
REHABILITATION IN MEXICO
Constantino-Casas P1,Torres-Arreola L2, Garcia-Contreras F2,
Castro-Rios A2, Nevarez-Sida A2, De Santillana-Hernandez S2,
Alejos-Carmona D2, Garduño-Espinosa J2
1Mexican Institute of Social Security, Mexico City, Mexico City,
Mexico; 2Mexican Institute of Social Security, Mexico City, Mexico
OBJECTIVE: To evaluate continuity of care (CoC) and social
capital in stroke patients under rehabilitation in the Mexican
Institute of Social Security (IMSS). METHODS: Cross sectional
study in three IMSS hospitals in Mexico City. Inclusion criteria
were: stroke adult patients surviving a ﬁrst ischaemic event,
consent to participate in the study and capable to answer ques-
tions in an interview. No instruments to measure CoC and social
capital in stroke patients were identiﬁed in our previous litera-
ture review. Three instruments to measure CoC were used:
Mexican one (Constantino), from United States (Chao) and from
Canada (Salmoni). The ﬁrst one is being validated and the other
two have been used and validated in general practice and chronic
patients discharged from hospital to community, respectively.
RESULTS: Forty stroke patients were interviewed, mean age was
68 years, education of 7 years and 87.5% had some chronic
illness (hypertension 58.3%). Sixty seven percent informed that
they were receiving formal rehabilitation and that in 88.2% it
met their needs and expectancies. The Mexican instrument (scale
from 1 to10) found a mean score for patient perception of CoC
of 7.1 and from carer/relative 8.1. Patients said they trusted their
doctor in 83.3% (Chao instrument). Opinion in relation to 
hospital care quality was: poor in 16.8%, regular in 12.5% 
and good/very good in 50% (Salmoni instrument). About social
capital: 91.6% trusted public institutions in their community and
in people living in the neighbourhood in 54.2%. Patients
received help to attend medical facilities in 4.2% from the neigh-
bour, 4.2% from a friend; patients helped the neighbour in
16.7% and a friend in 54.2%. CONCLUSIONS: Most of stroke
patients interviewed were satisﬁed with the quality of rehabili-
tation provided by the IMSS. CoC score from patient and carer
was acceptable and similar. Social capital level was also good.
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OBJECTIVES: This study assesses predictors of stroke recur-
rence in a Medicaid population, speciﬁcally examining persis-
tence on clopidogrel, warfarin and aspirin drug therapy.
METHODS: Medical and pharmacy claims for patients with a
diagnosis of stroke (ICD-9 Codes 430–438) were obtained from
Medicaid for the period of January 1, 2001–December 31, 2003.
Only patients with at least one month of follow up were
included. In order to obtain an incident cohort, patients who had
a stroke diagnosis between January 1, 2001–June 30, 2001 were
